Quinacrine: Clinical Trials

5 trials of Quinacrine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated, 1 withdrawn. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Recruiting 1, Terminated 1, Withdrawn 1
Phase 11Terminated 1

Follow Quinacrine: new trials by email Literature Review of Quinacrine trials Research Report on Quinacrine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus
Quinacrine Hydrochloride, Placebo - Cutaneous Lupus Erythematosus (CLE)
Phase 2RecruitingVictoria Werth242026-06-302026-08-12
Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma
Quinacrine and Capecitabine - Colorectal Adenocarcinoma
Phase 1 / Phase 2TerminatedFox Chase Cancer Center192016-01-142021-03-25
Treatment of Advanced Renal Cell Carcinoma With Quinacrine
quinacrine - Renal Cell Carcinoma
Phase 2WithdrawnCleveland BioLabs2007-11-012015-08-03
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
Quinacrine - Prostatic Cancer
Phase 2CompletedCleveland BioLabs312006-12-012013-04-11
CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
Quinacrine, Placebo - Creutzfeldt-Jakob Disease
Phase 2CompletedUniversity of California, San Francisco692005-04-012014-06-09

Conditions studied

Carcinoma, Renal Cell (1)  ·  Creutzfeldt-Jakob Syndrome (1)  ·  Dementia (1)  ·  Insomnia, Fatal Familial (1)  ·  Lupus Erythematosus, Cutaneous (1)  ·  Nervous System Diseases (1)  ·  Prion Diseases (1)  ·  Prostatic Neoplasms (1)

Sponsors

Cleveland BioLabs (2)  ·  Fox Chase Cancer Center (1)  ·  University of California, San Francisco (1)  ·  Victoria Werth (1)

Countries

United States (4)

Top investigators

Bruce L. Miller, MD (1)  ·  Crystal S. Denlinger, MD (1)  ·  Edwin Posadas, MD (1)  ·  John H Gordon, PhD (1)  ·  Michael Geschwind, MD, PhD (1)  ·  Victoria P Werth, MD (1)

Results publications

PMID 24122181

NIH funding

P01AG021601 (1)